[Elsevier] Vosoritide therapy in children with achondroplasia aged 3−59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial |
Reward10points
Best Answer
2024-4-28
|
| |
10
Metabolic switch regulates lineage plasticity and induces synthetic lethality in triple-negative breast cancer
10
Updates in Wound Management and Dressings
50
[Full book]Solar Hydrogen Production
10
A Comparison of the Association of Septal Scar Burden on Responses to LBBAP-CRT and BVP-CRT
10
[Other]Roadmap to Successful Digital Health Ecosystems
